Cargando…

An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency

BACKGROUND: Although there are many different expression systems for recombinant production of pharmaceutical proteins, many of these suffer from drawbacks such as yield, cost, complexity of purification, and possible contamination with human pathogens. Microalgae have enormous potential for diverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Hempel, Franziska, Maier, Uwe G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503769/
https://www.ncbi.nlm.nih.gov/pubmed/22970838
http://dx.doi.org/10.1186/1475-2859-11-126
_version_ 1782250504439463936
author Hempel, Franziska
Maier, Uwe G
author_facet Hempel, Franziska
Maier, Uwe G
author_sort Hempel, Franziska
collection PubMed
description BACKGROUND: Although there are many different expression systems for recombinant production of pharmaceutical proteins, many of these suffer from drawbacks such as yield, cost, complexity of purification, and possible contamination with human pathogens. Microalgae have enormous potential for diverse biotechnological applications and currently attract much attention in the biofuel sector. Still underestimated, though, is the idea of using microalgae as solar-fueled expression system for the production of recombinant proteins. RESULTS: In this study, we show for the first time that completely assembled and functional human IgG antibodies can not only be expressed to high levels in algal systems, but also secreted very efficiently into the culture medium. We engineered the diatom Phaeodactylum tricornutum to synthesize and secrete a human IgG antibody against the Hepatitis B Virus surface protein. As the diatom P. tricornutum is not known to naturally secrete many endogenous proteins, the secreted antibodies are already very pure making extensive purification steps redundant and production extremely cost efficient. CONCLUSIONS: Microalgae combine rapid growth rates with all the advantages of eukaryotic expression systems, and offer great potential for solar-powered, low cost production of pharmaceutical proteins.
format Online
Article
Text
id pubmed-3503769
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35037692012-11-22 An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency Hempel, Franziska Maier, Uwe G Microb Cell Fact Research BACKGROUND: Although there are many different expression systems for recombinant production of pharmaceutical proteins, many of these suffer from drawbacks such as yield, cost, complexity of purification, and possible contamination with human pathogens. Microalgae have enormous potential for diverse biotechnological applications and currently attract much attention in the biofuel sector. Still underestimated, though, is the idea of using microalgae as solar-fueled expression system for the production of recombinant proteins. RESULTS: In this study, we show for the first time that completely assembled and functional human IgG antibodies can not only be expressed to high levels in algal systems, but also secreted very efficiently into the culture medium. We engineered the diatom Phaeodactylum tricornutum to synthesize and secrete a human IgG antibody against the Hepatitis B Virus surface protein. As the diatom P. tricornutum is not known to naturally secrete many endogenous proteins, the secreted antibodies are already very pure making extensive purification steps redundant and production extremely cost efficient. CONCLUSIONS: Microalgae combine rapid growth rates with all the advantages of eukaryotic expression systems, and offer great potential for solar-powered, low cost production of pharmaceutical proteins. BioMed Central 2012-09-13 /pmc/articles/PMC3503769/ /pubmed/22970838 http://dx.doi.org/10.1186/1475-2859-11-126 Text en Copyright ©2012 Hempel and Maier; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Hempel, Franziska
Maier, Uwe G
An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency
title An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency
title_full An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency
title_fullStr An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency
title_full_unstemmed An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency
title_short An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency
title_sort engineered diatom acting like a plasma cell secreting human igg antibodies with high efficiency
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503769/
https://www.ncbi.nlm.nih.gov/pubmed/22970838
http://dx.doi.org/10.1186/1475-2859-11-126
work_keys_str_mv AT hempelfranziska anengineereddiatomactinglikeaplasmacellsecretinghumaniggantibodieswithhighefficiency
AT maieruweg anengineereddiatomactinglikeaplasmacellsecretinghumaniggantibodieswithhighefficiency
AT hempelfranziska engineereddiatomactinglikeaplasmacellsecretinghumaniggantibodieswithhighefficiency
AT maieruweg engineereddiatomactinglikeaplasmacellsecretinghumaniggantibodieswithhighefficiency